Regional
BC Emergency Health Services
BC Emergency Health Services (BC) carries 55 drugs across 118 dose entries in its current published protocol, effective 2026-01-16.
Drugs and doses55
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | peds | 15 mg/kg | PO | not captured | standing | page 434 |
| Mild to moderate pain | peds | 15 mg/kg | IV/PO | not captured | standing | page 467 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | peds | 0.2 mg/kg | IV | not captured | standing | page 442 |
| Narrow-complex tachycardia | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 398 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | peds | 5 mg/kg | IV/IO | not captured | standing | page 419 |
| Cardiac arrest | peds | 5 mg/kg | IV | not captured | standing | page 452 |
| Narrow-complex tachycardia | peds | 5 mg/kg | IV | not captured | standing | page 398 |
Andexanet Alfa
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 400 mg | IV | not captured | standing | page 217 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 160 mg | PO | not captured | standing | page 117 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | page 193 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 193 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1–2 g | IV | not captured | standing | page 341 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 20 mg/kg | IV | not captured | standing | page 341 |
| Cardiac arrest | adult | 1 g | IV/IO | not captured | standing | page 408 |
| Cardiac arrest | peds | 20 mg/kg | IV/IO | not captured | standing | page 408 |
| Hyperkalemia | adult | 1 g | IV | not captured | standing | page 229 |
| Hyperkalemia | peds | 20 mg/kg | IV | not captured | standing | page 229 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 1 g | IV | not captured | standing | page 229 |
| Hyperkalemia | peds | 1 g | IV | not captured | standing | page 229 |
Cisatracurium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.15–0.2 mg/kg | IV/IO | not captured | standing | page 112 |
| Other | peds | 0.15–0.2 mg/kg | IV/IO | not captured | standing | page 112 |
| Other | peds | 1–2 mcg/kg | IV/IO | not captured | standing | page 112 |
Dexamethasone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | peds | 0.6 mg/kg | IV/PO | not captured | standing | page 175 |
| Asthma / bronchospasm | peds | 0.6 mg/kg | IV/PO | not captured | standing | page 175 |
| Croup | peds | 0.6 mg/kg | IV/PO | not captured | standing | page 178 |
Dexmedetomidine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.1–0.8 mcg/kg | IV/IO | not captured | standing | page 112 |
| Other | peds | 0.1–0.8 mcg/kg | IV/IO | not captured | standing | page 112 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 10–25 g | IV/IO | not captured | standing | page 403 |
| Hypoglycemia | peds | 5 mL/kg | IV/IO | not captured | standing | page 403 |
Dimenhydrinate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 25–50 mg | IV | not captured | standing | page 117 |
| Nausea / vomiting | peds | 1.25 mg/kg | IV | not captured | standing | page 117 |
| Mild to moderate pain | adult | 25–50 mg | IV | not captured | standing | page 234 |
| Mild to moderate pain | peds | 1.25 mg/kg | IV | not captured | standing | page 234 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | peds | 1 mg/kg | IV/IM | not captured | standing | page 418 |
| Other | peds | 1 mg/kg | IV/IM | not captured | standing | page 473 |
Dobutamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 2–20 mcg/kg | IV | not captured | standing | page 212 |
| Hypotension / shock | peds | 2–20 mcg/kg | IV | not captured | standing | page 212 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 2–20 mcg | IV | not captured | standing | page 185 |
| Hypotension / shock | peds | 5–20 mcg/kg | IV | not captured | standing | page 185 |
| Other | adult | 2–20 mcg | IV | not captured | standing | page 112 |
| Other | peds | 5–20 mcg/kg | IV | not captured | standing | page 112 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3 mg | IM | not captured | standing | page 244 |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | page 418 |
| Anaphylaxis | peds | 0.15 mg | IM | not captured | standing | page 244 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 421 |
| Cardiac arrest | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 419 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.3 mg/kg | IV/IO | not captured | standing | page 112 |
| Other | peds | 0.3 mg/kg | IV/IO | not captured | standing | page 112 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | peds | 1–2 mcg/kg | IV/IO/IM | not captured | standing | page 445 |
| Mild to moderate pain | peds | 1.5–2 mcg/kg | IN | not captured | standing | page 445 |
Furosemide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 40 mg | IV | not captured | standing | page 212 |
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.1 mg/kg | IV | not captured | standing | page 490 |
Hydromorphone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 0.2–1 mg | SQ | not captured | standing | page 573 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 5 g | IV | not captured | standing | page 217 |
Ibuprofen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | peds | 10 mg/kg | PO | not captured | standing | page 434 |
Idarucizumab
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 5 g | IV | not captured | standing | page 217 |
Insulin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 10 unit | IV | not captured | standing | page 224 |
| Hyperkalemia | peds | 0.1 unit/kg | IV | not captured | standing | page 224 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 250 mcg | NEB | not captured | standing | page 174 |
| Asthma / bronchospasm | adult | 250 mcg | NEB | not captured | standing | page 174 |
| Asthma / bronchospasm | peds | 250 mcg | NEB | not captured | standing | page 174 |
| Asthma / bronchospasm | peds | 250 mcg | NEB | not captured | standing | page 174 |
Kayexalate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 30–60 g | PO | not captured | standing | page 229 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Procedural sedation | adult | 0.5 mg/kg | IV/IO | not captured | standing | page 58 |
| Procedural sedation | peds | 0.5–1 mg/kg | IV/IO | not captured | standing | page 58 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | peds | 0.5 mg/kg | IV/IM | not captured | standing | page 434 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | peds | 1 mg/kg | IV/IO | not captured | standing | page 419 |
| Other | adult | 40 mg | IO | not captured | standing | page 21 |
| Other | peds | 0.5 mg/kg | IO | not captured | standing | page 21 |
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2–4 g | IV | not captured | standing | page 175 |
| Asthma / bronchospasm | adult | 2–4 g | IV | not captured | standing | page 175 |
| Asthma / bronchospasm | peds | 25–75 mg/kg | IV | not captured | standing | page 175 |
| Asthma / bronchospasm | peds | 25–75 mg/kg | IV | not captured | standing | page 175 |
| Cardiac arrest | peds | 50 mg/kg | IV/IO | not captured | standing | page 408 |
| Eclampsia / pre-eclampsia | adult | 5 g | IV | not captured | standing | page 374 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 60 mg | IV | not captured | standing | page 175 |
Metoclopramide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 5 mg | SQ | not captured | standing | page 239 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Seizure | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 423 |
| Seizure | peds | 0.2 mg/kg | IM/IN | not captured | standing | page 423 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | peds | 0.05 mg/kg | IV/IO/IM | not captured | standing | page 423 |
N-Acetylcysteine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 150 mg/kg | IV | not captured | standing | page 345 |
| Other | peds | 150 mg/kg | IV | not captured | standing | page 345 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | peds | 0.1 mg/kg | IV/IM | not captured | standing | page 402 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | not captured | not captured | standing | page 117 |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | page 207 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 5–10 mcg | IV/IO | not captured | standing | page 112 |
| Other | peds | 5–60 mcg | IV/IO | not captured | standing | page 112 |
Octaplex
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 25–50 unit/kg | IV | not captured | standing | page 216 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | peds | 4 mg | SQ/PO | not captured | standing | page 239 |
Phenylephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 50–100 mcg | IV/IO | not captured | standing | page 112 |
| Other | peds | 0.5–6 mcg/kg | IV/IO | not captured | standing | page 112 |
Phenytoin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Seizure | peds | 1250 mg | IV | not captured | standing | page 255 |
Pralidoxime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Organophosphate poisoning | adult | 1–2 g | IV | not captured | standing | page 332 |
| Organophosphate poisoning | peds | 20–50 mg/kg | IV | not captured | standing | page 332 |
Prednisone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 40 mg | PO | not captured | standing | page 175 |
| Asthma / bronchospasm | adult | 40 mg | PO | not captured | standing | page 175 |
| Asthma / bronchospasm | adult | 40 mg | PO | not captured | standing | page 175 |
Propofol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 50–200 mcg/kg | IV/IO | not captured | standing | page 112 |
| Other | peds | 1–3 mg/kg | IV/IO | not captured | standing | page 112 |
| Other | peds | 50–200 mcg/kg | IV/IO | not captured | standing | page 112 |
Protamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mg | IV | not captured | standing | page 216 |
Pyridoxine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Seizure | peds | 50–100 mg | IV | not captured | standing | page 539 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.6–1.2 mg/kg | IV/IO | not captured | standing | page 112 |
| Other | peds | 0.6–1 mg/kg | IV/IO | not captured | standing | page 112 |
Salbutamol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2.5 mg | NEB | not captured | standing | page 418 |
| Asthma / bronchospasm | adult | 2.5 mg | NEB | not captured | standing | page 418 |
| Asthma / bronchospasm | peds | 2.5 mg | NEB | not captured | standing | page 418 |
| Asthma / bronchospasm | peds | 2.5 mg | NEB | not captured | standing | page 418 |
| Hyperkalemia | adult | 10–20 mg | NEB | not captured | standing | page 39 |
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 1 mEq/kg | IV/IO | not captured | standing | page 408 |
| Cardiac arrest | peds | 1 mEq/kg | IV/IO | not captured | standing | page 408 |
| Hyperkalemia | adult | 150 mEq | IV | not captured | standing | page 224 |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.6–1.1 mg/kg | IV/IO | not captured | standing | page 112 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 1 g | IV/IO | not captured | standing | page 371 |
| Obstetric hemorrhage | peds | 15 mg/kg | IV/IO | not captured | standing | page 371 |
| Trauma / hemorrhage | adult | 1 g | IV/IO | not captured | standing | page 422 |
| Trauma / hemorrhage | peds | 15 mg/kg | IV/IO | not captured | standing | page 422 |
Vitamin K
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10 mg | IV | not captured | standing | page 216 |